With reference to DEBRA UK's press release entitled EB patients being failed by prescription changes, published on 22 May 2026, what assessment he has made of the potential implications for his policies that four-fifths of epidermolysis bullosa patients have experienced unwarranted and potentially harmful changes by their GP surgeries to prescriptions for dressings and medication previously made by EB consultants.
Awaiting answer.
